Welcome!
CGS-CIMB Research
Broker's Calls
Brokers' Digest: Suntec REIT, Tiong Woon, MLT, Keppel DC REIT, ComfortDelGro, Hyphens Pharma, Frencken
See what the analysts have to say this week.
October 27, 2023
Broker's Calls
Maybank Securities maintains 'buy' call on FEHT on distribution stability and robust outlook
'FEHT offers a stable distribution profile and a lowly geared balance sheet'
October 26, 2023
Broker's Calls
Analysts remain positive on Keppel after 3QFY2023 business update; PhillipCapital upgrades to ‘buy’
The analysts from CGS-CIMB, DBS and PhillipCapital have target prices of $8.70, $8.05 and $7.52 respectively.
October 23, 2023
Broker's Calls
Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma
Although the incremental net profit contribution is likely negligible near term, the deal presents cross-selling opportunities.
October 23, 2023
Broker's Calls
CGS-CIMB lifts Frencken’s TP to $1.37 on improving outlook
Frencken is expected to release its 3QFY2023 update by Nov 27.
October 20, 2023
Broker's Calls
Brokers’ Digest: OCBC, Centurion, Frasers Property, Aztech Global, Sats, SIA
Here's what the analysts have to say this week.
October 20, 2023
Broker's Calls
Lady luck shall return, analysts keep 'buy' on Genting Singapore
UOBKH analyst believes Genting Singapore would deliver sequentially higher earnings q-o-q compared to MBS in 3QFY2023.
October 20, 2023
Investing ideas
Analysts positive on Keppel DC REIT after 3Q meets expectations
CGS-CIMB Research and DBS Group Research kept their "add" and "buy" calls while Citi and OCBC remained "neutral".
October 19, 2023
Broker's Calls
CGS-CIMB upgrades AEM to ‘add’ with higher TP of $4.11
The company is estimated to see a recovery in net profit in FY2025 as demand from its key customer, Intel, returns.
October 19, 2023
Broker's Calls
CGS-CIMB upgrades Grand Venture Tech to ‘add’ with higher TP of 62 cents
The upgrade comes as analyst William Tng sees earnings improvement to happen in FY2024 and FY2025.
October 19, 2023